Physician

Ali Akbar Zaidi, MD

According to 2025 Medicare claims, Ali Zaidi, MD (NPI: 1417006479) practices ophthalmology in the San Francisco-San Mateo-Redwood City, CA market, with the plurality of this provider's patient population coming from San Francisco, CA. This provider's primary affiliated billing organization is PACIFIC EYE ASSOCIATES, A MEDICAL CORPORATION (NPI: 1265464739; TIN: 943228329) and primary practice location at 94115-2375.

Zaidi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,131 traditional Medicare patients, billed 13,812 HCPCS/CPT codes, and received $737,431 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 312 prescription claims across 99 beneficiaries totaling $100,568 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 49 records totaling $1,421. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $496,945 to $737,431. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $41,629 and ending at $100,568. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$421K$842K2015 Medicare payment: $496,945 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $532,391 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $612,832 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $632,430 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $735,878 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $562,486 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $841,582 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $754,586 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $788,719 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $737,431 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158343,877$496,945
20169194,612$532,391
20179694,676$612,832
20181,0784,948$632,430
20191,0685,385$735,878
20209684,326$562,486
20211,2726,267$841,582
20221,2337,147$754,586
20231,20612,001$788,719
20241,13113,812$737,431

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$95K$190K2015 Drug cost: $41,629 (USD; Tot_Drug_Cst)2016 Drug cost: $61,632 (USD; Tot_Drug_Cst)2017 Drug cost: $121,459 (USD; Tot_Drug_Cst)2018 Drug cost: $123,665 (USD; Tot_Drug_Cst)2019 Drug cost: $161,261 (USD; Tot_Drug_Cst)2020 Drug cost: $120,575 (USD; Tot_Drug_Cst)2021 Drug cost: $147,399 (USD; Tot_Drug_Cst)2022 Drug cost: $189,624 (USD; Tot_Drug_Cst)2023 Drug cost: $144,648 (USD; Tot_Drug_Cst)2024 Drug cost: $100,568 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015135372$41,629
2016165380$61,632
2017163493$121,459
2018164450$123,665
2019163575$161,261
2020136465$120,575
2021172540$147,399
2022160499$189,624
2023131384$144,648
202499312$100,568

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye181522$96
92014Established patient complete exam of visual system1,0121,523$94
J9035Injection, bevacizumab, 10 mg100282$56
92134Imaging of retina7051,367$33
92250Photography of the retina102104$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast321,350$30,654
EysuvisLoteprednol Etabonate35825$19,100
RestasisCyclosporine14600$12,697
LumiganBimatoprost211,386$9,235
CombiganBrimonidine Tartrate/Timolol11718$5,555

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.49$1,421ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ali Akbar Zaidi, MD?

Tedicare shows public-source Medicare data for Ali Akbar Zaidi, MD (NPI 1417006479), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Akbar Zaidi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Akbar Zaidi, MD?

Ali Akbar Zaidi, MD is linked to PACIFIC EYE ASSOCIATES, A MEDICAL CORPORATION (billing NPI 1265464739) in the available physician profile data.

Does Ali Akbar Zaidi, MD have Open Payments data?

Ali Akbar Zaidi, MD has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.